That's always the goal. Public Health teaches the (increasingly controversial) concept of the Iron Triangle, which identifies the basic pillars of healthcare as quality, cost, and access. The idea is that changing to one or two of these pillars will affect the third. It's all about finding the proper balance.
Bit of a tangent, but I'm all about the U.S. leading the world in medical drug research and device development. We cured hepatitis C a few years ago. I know a few people who worked on the team that did it, and their work is amazing. But I don't think the promise of corporate drug research requires us to submit to the pricing whims of pharmaceutical companies while the rest of the world aggressively negotiates deals on the very same prescription drugs. Even though I think research is the key to the future, I cannot support a situation where America largely subsidizes global pharmaceutical R&D, yet is increasingly unable to afford the very drugs we help develop.